HomeTopic Collection
Topic Collection
Advances in Clinical Psychopharmacology in Children and Young People
Clinical psychopharmacology is a developing field with relevant unmet needs and opportunities, such as understanding the best use of currently available medications, gaining insight into their specific effects in the developmental stage of life, and the testing of new medications. This Topic Collection in BMJ Mental Health discusses this through high quality empirical original studies or evidence synthesis papers on relevant aspect of clinical psychopharmacology in children and/or young people.
Guest Editors
Samuele Cortese
University of Southampton
orcid.org/0000-0001-5877-8075
orcid.org/0000-0001-5877-8075Carmen Moreno
Hospital General Universitario Gregorio Marañón
orcid.org/0000-0003-0541-4846
orcid.org/0000-0003-0541-4846Editorial
Advancing the evidence base for child and adolescent psychopharmacology (3 March 2025)
Samuele Cortese, Carmen Moreno
Original Research
Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorder (20 April 2025)
Eli Magen, Eugene Merzon, Akim Geishin, Shai Ashkenazi, Iris Manor, Shlomo Vinker, Ilan Green, Avivit Golan-Cohen, Abraham Weizman, Ariel Israel
Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study (19 September 2024)
Ingvild Lyhmann, Tarjei Widding-Havneraas, Ingvar Bjelland, Simen Markussen, Felix Elwert, Ashmita Chaulagain, Arnstein Mykletun, Anne Halmøy
Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults (12 April 2024)
Jacques Hamard, Vanessa Rousseau, Geneviève Durrieu, Philippe Garcia, Antoine Yrondi, Agnès Sommet, Alexis Revet, François Montastruc
Quality of melatonin use in children and adolescents: findings from a UK clinical audit (22 January 2024)
Carol Paton, Paul Gringras, Alice Ruan, Ashley Liew, Olivia Rendora, Gaia Bove, Thomas R E Barnes
Systematic Review
Comparing apples and oranges in youth depression treatments? A quantitative critique of the evidence base and guidelines (19 January 2025)
Argyris Stringaris, Charlotte Burman, Raphaelle Delpech, Rudolph Uher, Dayna Bhudia, Despoina Miliou, Ioannis-Marios Rokas, Marinos Kyriakopoulos, Lucy Foulkes, Carmen Moreno, Samuele Cortese, Glyn Lewis, Georgina Krebs
Letter
Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors (19 June 2024)
Sem E Cohen, Damiaan A J P Denys, Taina Kristiina Mattila, Bram W C Storosum, Anthonius de Boer, Jasper Brian Zantvoord
All submitted articles have been subject to the journal's normal peer review process. The Editor in Chief is responsible for the content of this Topic Collection. Guest Editors managed peer review, invited reviewers and made recommendations, but the final decision on all manuscripts has been made by the Editor-in-Chief.
This collection closed for submissions on the 30th of April 2024. For any inquiries regarding this topic collection, please contact topic.collections@bmj.com.
keywords: Psychopharmacology; Children; Adolescents; Young People; randomised controlled trials; ADHD; Autistic Spectrum Disorder; anxiety disorders; obsessive compulsive disorder; major depressive disorder; antidepressants; SSRIs; SRNIs; TCAs; antipsychotics; efficacy; tolerability